Jeffrey Trigilio - Net Worth and Insider Trading
Jeffrey Trigilio Net Worth
The estimated net worth of Jeffrey Trigilio is at least $1 Million dollars as of 2024-11-28. Jeffrey Trigilio is the CFO of Cullinan Therapeutics Inc and owns about 83,919 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $1 Million. Details can be seen in Jeffrey Trigilio's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeffrey Trigilio has not made any transactions after 2023-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeffrey Trigilio
Jeffrey Trigilio Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeffrey Trigilio owns 1 companies in total, including Cullinan Therapeutics Inc (CGEM) .
Click here to see the complete history of Jeffrey Trigilio’s form 4 insider trades.
Insider Ownership Summary of Jeffrey Trigilio
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2023-12-21 | Chief Financial Officer |
Jeffrey Trigilio Latest Holdings Summary
Jeffrey Trigilio currently owns a total of 1 stock. Jeffrey Trigilio owns 83,919 shares of Cullinan Therapeutics Inc (CGEM) as of December 21, 2023, with a value of $1 Million.
Latest Holdings of Jeffrey Trigilio
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2023-12-21 | 83,919 | 13.09 | 1,098,500 |
Holding Weightings of Jeffrey Trigilio
Jeffrey Trigilio Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeffrey Trigilio has made a total of 13 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 1 buys and 12 sells. The most-recent trade in Cullinan Therapeutics Inc is the sale of 1,920 shares on December 21, 2023, which brought Jeffrey Trigilio around $16,320.
Insider Trading History of Jeffrey Trigilio
- 1
Jeffrey Trigilio Trading Performance
GuruFocus tracks the stock performance after each of Jeffrey Trigilio's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeffrey Trigilio is 0.95%. GuruFocus also compares Jeffrey Trigilio's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeffrey Trigilio within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeffrey Trigilio's insider trading performs compared to the benchmark.
Performance of Jeffrey Trigilio
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 35.18 | | | | | |
| Relative Return to S&P 500(%) | 31.66 | | | | | |
Jeffrey Trigilio Ownership Network
Jeffrey Trigilio Owned Company Details
What does Cullinan Therapeutics Inc do?
Who are the key executives at Cullinan Therapeutics Inc?
Jeffrey Trigilio is the Chief Financial Officer of Cullinan Therapeutics Inc. Other key executives at Cullinan Therapeutics Inc include See Remarks Jennifer Michaelson , Acting Chief Business Officer Savill Corrine , and director & President and CEO Nadim Ahmed .
Cullinan Therapeutics Inc (CGEM) Insider Trades Summary
Over the past 18 months, Jeffrey Trigilio made 5 insider transaction in Cullinan Therapeutics Inc (CGEM) with a net sale of 4,962. Other recent insider transactions involving Cullinan Therapeutics Inc (CGEM) include a net sale of 102,471 shares made by Jennifer Michaelson , a net sale of 120,000 shares made by Savill Corrine , and a net sale of 2,633 shares made by Jeffrey Alan Jones .
In summary, during the past 3 months, insiders sold 16,000 shares of Cullinan Therapeutics Inc (CGEM) in total and bought 0 shares, with a net sale of 16,000 shares. During the past 18 months, 237,078 shares of Cullinan Therapeutics Inc (CGEM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 237,078 shares.
Cullinan Therapeutics Inc (CGEM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cullinan Therapeutics Inc Insider Transactions
Jeffrey Trigilio Mailing Address
Above is the net worth, insider trading, and ownership report for Jeffrey Trigilio. You might contact Jeffrey Trigilio via mailing address: C/o Cullinan Management, Inc., One Main Street, Sutie 520, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
